肚子疼是很常见的不适症状,一般人也不会选择去医院,只有持续性或突发剧烈性的腹痛,人们才会到医院接受检查治疗,简单的腹痛,可以吃一些药或者饮食调理即可.而且在用药方面也将就,经常搞不清楚原因就乱用药: 一、肚子不舒服的常见用药 1、服用诺氟沙星 腹泻引起的腹痛,一种是食物中毒,另外一种是因为不适应环境而导致的,如果只有轻微的腹痛,没有发烧等症状,只需服用一些抗生素和抗痉挛药,如诺氟沙星.如果你想立即缓解腹泻,也可以服用一些胃肠药物,如此效果才比较不错,它能迅速减缓液体通过肠道的速度,减轻腹泻引起的不适.

胃癌是一种特别常见的恶性肿瘤，我国农村地区发病率相对较高。胃癌发病率存在地理差异，如西北、东南地区发病率明显偏高，华北、内陆地区发病率相对较低。相关文献报道，胃癌是世界上发生最广泛的肿瘤之一，在我国胃癌发病率居全国第二位。

目的 分析某基层医院门诊幽门螺杆菌对常用抗生素耐药情况.方法 随机收集于我院门诊行胃镜检查患者512例,于患者胃窦部取黏膜标本用于HP培养,以我院常用抗生素阿莫西林、甲硝唑、克拉霉素、左氧氟沙星、四环素对培养出的菌株行药物敏感试验.结果 HP培养阳性率为50.98％,药敏试验中耐药率最高为甲硝唑,左氧氟沙星、克拉霉素耐药率逐年升高,阿莫西林、四环素耐药率均较低.结论 为提高我院幽门螺杆菌根除率,推荐门诊消化科医生使用阿莫西林、四环素为首选用药.

Objective:To evaluate the efficacy of abdominal paracentesis drainage ( APD) ahead of percutaneous catheter drainage ( PCD) in the replacement of PCD-alone treatment as the new second step of a step-up approach for acute pancreatitis ( AP).Methods:102 consecutive AP patients were admitted from June 2009 to June 2011.According to whether or not APD was applied , they were divided into two groups: 53 Patients in APD +PCD group , 49 ones in PCD-alone group.Observed parameters mainly included mortality , the incidence of recurrent AP or chronic pancreatitis ( CP) , organ failures and the indexes of further interventions.Results: The mortality rate in the APD +PCD group was 3.77% while the PCD-alone group was 8.16%;the APD+PCD group showed significantly lower mortality rate than the PCD-alone group(P<0.05).After 2-year follow-up, the incidence of recurrent AP and CP in the APD +PCD group was 7.84% and 5.88% while the PCD-alone group was 14.29%and 8.16%, respectively;the APD +PCD group showed significantly lower recurrent incidence than the PCD-alone group(P<0.05).Compared with the PCD-alone group, the number of organs failed was decreased , the interval from the onset of AP to further interventions was remarkably delayed , and the cost of hospitalization significantly reduced in the APD +PCD group.Conclusion:APD ahead of PCD is beneficial to AP patients , which is simple and worthy of clinical application.

ObjectiveTo investigate the effect of butyric acid bacteria bifidobacteria duplex living bacterium combined with montmorillonite powder in the treatment of acute gastroenteritis.Method200 cases of acute gastroenteritis patients from June 2013 to June 2014 treated in our hospital were selected as the research objects, they were divided into control group and experimental group, control group patients were given butyric acid bacillus biifdobacterium duplex living bacterium alone. Experimental group patients were treated with butyric acid bacteria biifdobacteria duplex living bacterium combined with montmorillonite powder. The curative effect, clinical symptom scores before and after treatment, serum biochemical index levels and adverse reactions were compared between the two groups.ResultThere were no significant differences in clinical symptom scores and total scores between the two groups before and after treatment (P>0.05); the clinical symptom scores and total scores of the two groups after treatment were signiifcantly improved (P<0.05), experimental group were lower than control group (P<0.05). Before treatment, the levels of serum PCT, IL-8, IL-6 in the two groups were higher than normal, and the differences between the two groups were not signiifcant (P>0.05); after treatment the indexes in the two groups were signiifcantly decreased (P<0.05), experimental group were lower than control group (P<0.05). The total effective rate&nbsp;of experimental group was signiifcantly higher than control group (P<0.05). Two groups patients in the treatment of drug resistance was good, no obvious adverse reactions occurred.ConclusionButyric acid bacteria biifdobacteria duplex living bacterium can inhibit the growth of pathogenic bacteria, montmorillonite powder can reduce or eliminate pathogens, adsorption, strengthen the body resistance. So the two combination can effectively improve the degree of bacterial infection, reduce inlfammatory reaction cell, improve clinical symptoms.

目的探讨一种安全、有效的肠道清洁剂应用于临床实际工作中。方法取30%硫酸镁、20%甘露醇、磷酸钠,采取随机分组法将接受结肠镜检查的患者分为A组、B组、C组。对肠道准备有效性、患者耐受性及安全性进行评价。结果磷酸钠组患者肠道准备有效性方面高于硫酸镁、甘露醇组。甘露醇、磷酸钠组患者愿再次服药率高于硫酸镁组,硫酸镁、甘露醇组患者不良反应高于磷酸钠组(P<0.05)。结论磷酸盐是更为安全、有效的肠道清洁剂。

Objective To assess the effectiveness and safety of chaishao chengqi decoction in the treatment of patients with severe acute pancreatitis.Methods We searched studies about chaishao chengqi decoction in the treatment of patients with severe acute pancreatitis .Randomized controlled trials or quasi-randomized trial of chaishao chengqi decoction for acute pancreatitis,we evaluated the quality of the included studies by Handbook 4.2.2 recommend standard and analyzed data by Cochrane Collaboration′s RevMan 4.2.7.We included 9 trials (n=534).Results Meta-analyses showed that the clinical effective rate of chaishao chengqi decoction plus based treatment group significantly was higher than based treatment group.Conclusion The current evidence showed chaishao chengqi decoction plus based treatment has better effectiveness when compared with based treatment.Further high quality and large sample randomized controlled trials should be carried out.

免疫球蛋白A(IgA)肾病是以IgA或IgA为主的免疫球蛋白在肾小球系膜弥漫沉积为特征的肾小球肾炎.原发性IgA肾病是我国最常见的肾小球疾病之一,是导致终末期肾功能衰竭的一个主要原因[1].

Objective To evaluate the efficacy and safety of endoscopic variceal ligation (EVL) versus endoscopic variceal sclerotherapy (EVS) for acute esophageal variceal bleeding patients with liver cirrhosis.Methods We searched CBMdisc (1979 to 2006),CNKI (1994 to 2006) and VIP for randomized controlled trials (RCTs) and quasi-RCTs comparing EVL and EVS for acute esophageal variceal bleeding patients with liver cirrhosis.The methodogical quality of included trials was critically assessed and the data were extracted by two reviewers independently.RevMan 4.2.7 software was used for meta-analysis.Results Nine RCTs involving a total of 1 371 patients were included,of which 688 in EVL group and 683 in EVS group.The results of meta-analysis showed:for mortality[RR 0.60,95%CI (0.36,0.98)],the rate of complications,rebleeding and emergency hemostasis,EVL was better than EVS,but a significant difference was only found in mortality;for the rate of eradication varices and recurrent varices,EVS was better than EVL,but no significant difference was found.Conclusions For acute esophageal variceal bleeding patients with liver cirrhosis,EVL has better effect and fewer complications.However,because the quality of included RCTs was poor,the strength of our conclusions was limited. Further high-quality RCTs are required.

Objective To assess the effectiveness and safety of mycophenolate mofetil (MMF) in the treatment of proliferative lupus nephritis. Methods We searched CBM (November 1979 to February 2006), Chinese Cochrane Centre Database (2005), The Cochrane Library (Issue 4, 2005), MEDLINE (November 1966 to February 2006) and EMBASE (1975 to February 2006) for randomize controlled trials. Data were extracted and analyzed using The Cochrane Collaboration's RevMan 4.2.7. Results Nine randomize controlled trials involving 512 patients met the inclusion criteria. The meta-analysis showed that the total clinical effective rate and complete remission rate were not significantly higher for MMF than for cyclophosphamide, azathioprine, or both. Renal survival rate and relapse rate of MMF were not significantly different from those for cyclophosphamide, azathioprine, or both. Patient survival rate and safety of MMF were significantly improved compared with cyclophosphamide, azathioprine, or both. Conclusion More large-scale multi-center randomized trials are needed to investigate the role of MMF in the treatment of proliferative lupus nephritis.

AIM:To evaluate the efficacy of esomeprazole in the treatment of gastroesephageal reflux disease (GERD) when compared to the other PPI. METHODS:We were searching RCT researchers contacted. The quality evaluation of studies and data analysis were conducted by the methods of the Cochrane Collaboration. RESULTS:Fourteen RCTs met the inclusion criteria. In patients with NERD symptom relief rate esomeprazole had significant effect when compared with pantoprazole. In patients with EE symptom relief rate esomeprazole had significant effect comparing with the other PPI. CONCLUSION:Esomeprazole was better than pantoprazole in patients with NERD symptom relief rate. In patients with EE symptom relief rate esomeprazole was better than the other PPI.